Cue Biopharma, Inc. — All Filings
479 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
10-Q/A
144
3
3/A
4
4/A
424B1
424B3
424B5
424B7
5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
CT ORDER
D
D/A
DEF 14A
DEFA14A
EFFECT
FWP
POS AM
POSASR
PRE 14A
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| DEFA14A | DEFA14A | 0001193125-26-129007 | Mar 27, 2026 | — |
| 8-K | 8-K | 0001193125-26-128993 | Mar 27, 2026 | Mar 23, 2026 |
| S-3 | S-3 | 0001193125-26-108656 | Mar 16, 2026 | — |
| ARS | ARS | 0001193125-26-108307 | Mar 16, 2026 | Dec 31, 2025 |
| DEF 14A | DEF 14A | 0001193125-26-108301 | Mar 16, 2026 | — |
| 8-K | 8-K | 0001193125-26-108292 | Mar 16, 2026 | — |
| 10-K | 10-K | 0001193125-26-108287 | Mar 16, 2026 | Dec 31, 2025 |
| PRE 14A | PRE 14A | 0001193125-26-096441 | Mar 6, 2026 | — |
| 8-K | 8-K | 0001193125-26-056983 | Feb 18, 2026 | — |
| 8-K | 8-K | 0001193125-26-047717 | Feb 12, 2026 | Feb 9, 2026 |
| 4 | 4 | 0001193125-26-004359 | Jan 6, 2026 | Jan 2, 2026 |
| 4 | 4 | 0001193125-26-004358 | Jan 6, 2026 | Jan 2, 2026 |
| 4 | 4 | 0001193125-26-004356 | Jan 6, 2026 | Jan 2, 2026 |
| 4 | 4 | 0001193125-26-004357 | Jan 6, 2026 | Jan 2, 2026 |
| 4 | 4 | 0001193125-26-004355 | Jan 6, 2026 | Jan 2, 2026 |
| 4 | 4 | 0001193125-26-004354 | Jan 6, 2026 | Jan 2, 2026 |
| 4 | 4 | 0001193125-26-000900 | Jan 2, 2026 | Dec 30, 2025 |
| 144 | — | 0001950047-25-010720 | Dec 29, 2025 | — |
| 8-K | 8-K | 0001193125-25-326925 | Dec 19, 2025 | — |
| 424B5 | 424B5 | 0001193125-25-326847 | Dec 19, 2025 | — |
| 424B5 | 424B5 | 0001193125-25-324820 | Dec 18, 2025 | — |
| 4 | 4 | 0001193125-25-310067 | Dec 5, 2025 | Sep 26, 2025 |
| 4 | 4 | 0001193125-25-296986 | Nov 25, 2025 | Sep 29, 2025 |
| 4 | 4 | 0001193125-25-296985 | Nov 25, 2025 | Sep 29, 2025 |
| 8-K | 8-K | 0001193125-25-292093 | Nov 24, 2025 | — |
| 8-K | 8-K | 0001193125-25-289713 | Nov 20, 2025 | Nov 17, 2025 |
| 10-Q | 10-Q | 0001193125-25-277466 | Nov 12, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001193125-25-277468 | Nov 12, 2025 | — |
| 8-K | 8-K | 0001193125-25-268135 | Nov 6, 2025 | — |
| 4 | 4 | 0001193125-25-228920 | Oct 2, 2025 | Sep 29, 2025 |
| 3 | 3 | 0001193125-25-228919 | Oct 2, 2025 | Sep 29, 2025 |
| 8-K | 8-K | 0000950130-25-000140 | Sep 29, 2025 | Sep 26, 2025 |
| S-8 | S-8 | 0000950170-25-107323 | Aug 12, 2025 | — |
| 10-Q | 10-Q | 0000950170-25-107270 | Aug 12, 2025 | Jun 30, 2025 |
| 8-K | 8-K | 0000950170-25-107268 | Aug 12, 2025 | — |
| 8-K | 8-K | 0000950170-25-092168 | Jul 1, 2025 | Jun 30, 2025 |
| 8-K | 8-K | 0000950170-25-084279 | Jun 10, 2025 | Jun 4, 2025 |
| 4 | 4 | 0000950170-25-083026 | Jun 6, 2025 | Jun 4, 2025 |
| 3 | 3 | 0000950170-25-083025 | Jun 6, 2025 | Jun 4, 2025 |
| DEFA14A | DEFA14A | 0000950170-25-077389 | May 27, 2025 | — |
| SCHEDULE 13G/A | — | 0001213900-25-044863 | May 16, 2025 | — |
| 10-Q | 10-Q | 0000950170-25-069125 | May 12, 2025 | Mar 31, 2025 |
| 8-K | 8-K | 0000950170-25-069124 | May 12, 2025 | — |
| ARS | ARS | 0000950170-25-058683 | Apr 25, 2025 | Dec 31, 2024 |
| DEF 14A | DEF 14A | 0000950170-25-058681 | Apr 25, 2025 | Jun 3, 2025 |
| DEFA14A | DEFA14A | 0000950170-25-058677 | Apr 25, 2025 | — |
| 8-K | 8-K | 0001193125-25-081592 | Apr 15, 2025 | Apr 14, 2025 |
| 424B5 | 424B5 | 0001193125-25-081566 | Apr 15, 2025 | — |
| 424B5 | 424B5 | 0001193125-25-080293 | Apr 14, 2025 | — |
| 8-K | 8-K | 0001193125-25-080277 | Apr 14, 2025 | Apr 10, 2025 |